VAIA
DGX icon

Virtus Alternative Investment Advisers’s Quest Diagnostics DGX Stock Holding History

Virtus Alternative Investment Advisers’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-137
Closed -$16K – 277
2020
Q2 		$16K Sell
137
-128
-48% -$13.6K 0.25% 101
2020
Q1 		$21K Buy
265
+180
+212% +$18.6K 0.29% 187
2019
Q4 		$9K Buy
+85
New +$8.86K 0.14% 102

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Virtus Alternative Investment Advisers's DGX Position: Q3 2020 in Review

Virtus Alternative Investment Advisers sold out of Quest Diagnostics (DGX) in Q3 2020, closing a stake of 137 shares — an estimated $16K sold.

Virtus Alternative Investment Advisers first reported a position in DGX in Q4 2019 and held it in 3 quarters. The position peaked at $21K in Q1 2020. 757 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

  • Virtus Alternative Investment Advisers reported no remaining Quest Diagnostics position as of Q3 2020 after selling out during the quarter.
  • Virtus Alternative Investment Advisers sold 137 Quest Diagnostics shares in Q3 2020, an estimated $16K.
  • Virtus Alternative Investment Advisers first reported a position in Quest Diagnostics in Q4 2019 and held it in 3 quarters.
  • Virtus Alternative Investment Advisers's Quest Diagnostics position peaked at $21K in Q1 2020.
  • 757 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on Virtus Alternative Investment Advisers's 13F filing for Q3 2020, filed 13 Nov 2020.